Prescription medicine
Cupric chloride Brand names: Copper
Cupric chloride (Copper) is a prescription medicine with an FDA approval on record since 1986. FDA's NDC Directory lists it from 6 generic labelers.
- Generic listed
Check it at the source: the cupric chloride FDA label on DailyMed (effective February 4, 2026, Amneal Pharmaceuticals Private Limited); the NDA 18960 record on Drugs@FDA; every cupric chloride label on DailyMed.
Highlights of the record
FDA label of February 4, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageCupric chloride injection is indicated for use as a supplement to intravenous solutions given for TPN.
Forms and strengths
- 0.4 mg/ml
Injection (solution); injection.
On the market
- Earliest approval on file
- June 26, 1986 Cupric Chloride In Plastic Container, Hospira; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 4 first October 31, 2022; 3 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 7 of which 6 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 730 through July 30, 2026
What is cupric chloride used for?
From the label: indications and usageCupric chloride injection is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Source: FDA drug label (CUPRIC CHLORIDE), Amneal Pharmaceuticals Private Limited, effective February 4, 2026 (SPL set c431cc76-f9ba-43c7-8d66-e93c77fa6229), via openFDA; the full label on DailyMed
Is there a generic for cupric chloride (Copper)?
The FDA approved the first generic cupric chloride on October 31, 2022. 4 generic applications are approved; 3 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists cupric chloride from 6 labelers under a generic (ANDA) application and from 1 brand labeler. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1986 earliest approval on file
- 2022 first generic approved
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do FAERS reports show for cupric chloride?
The FDA Adverse Event Reporting System holds 730 reports that list cupric chloride among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 39 are coded as a death and 216 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Cupric chloride side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other